“Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations ”, Rev Diabet Stud, vol. 6, no. 2, Aug. 2023, Accessed: Sep. 13, 2025. [Online]. Available: https://diabeticstudies.org/index.php/RDS/article/view/259